BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY
NCT: NCT05443451 · COMPLETED
NCT IDNCT05443451
StatusCOMPLETED
Start Date2022-09-08
Completion2023-10-30
SponsorChinese University of Hong Kong (OTHER)
First posted
Last updated
Brief Summary
This is a pilot study on applying 3D-Ultrasound-Guided Transperineal Microwave needle ablation for men with symptomatic benign prostatic hyperplasia (BPH).
Frequently Asked Questions
What is BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY?
BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY is a clinical trial registered under NCT05443451. Current status: COMPLETED.
What is the status of NCT05443451?
The current status of NCT05443451 (BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY) is: COMPLETED.
When did BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY start?
BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY started on 2022-09-08.
Related Devices
PMA P010055System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapyProstalund AB
PMA P030006System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapyMedifocus, Inc.
K200061HEATfx Microwave Ablation System, HEATfx Microwave Ablation System Cart, HEATfx 2.1 Needle, HEATfx 2.1 S Needle, Multi-Point Thermal Sensor (MTS)Galil Medical, Inc.
K232241Disposable Microwave Ablation Needle (T-1408, T-1410, T-1608, T-1610, L-1815, L-1818, L-2015, L-2018)Betters(Suzhou) Medical Co., Ltd.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.